A Phase Ib Open-label, Multicenter Cross-over Study to Investigate the Effect of Food on the Rate and Extent of Oral LBH589 [panobinostat] Absorption in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2012
At a glance
- Drugs Panobinostat (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Novartis
- 10 Jan 2012 Actual end date (1 Feb 2011) added as reported by ClinicalTrials.gov.
- 17 Jun 2009 Status changed from recruiting to completed.
- 02 Jun 2009 Results presented at the 45th Annual Meeting of the American Society of Clinical Oncology